Sleep-Disordered Breathing and Prognosis after Ischemic Stroke: It Is Not Apnea-Hypopnea Index That Matters
Diagnostics · 03.07.2023 · 13 (13) · 2246
DOI: 10.3390/diagnostics13132246 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 03.07.2023. Verfasst von Lyudmila Korostovtseva und 12 weiteren Autor:innen. Beteiligte Einrichtung: Almazov National Medical Research Centre, 197341 St. Petersburg, Russia. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.
Themen: Schlaganfall
Abstract (Originalsprache)
Background
Sleep-disordered breathing (SDB) is highly prevalent after stroke and is considered to be a risk factor for poor post-stroke outcomes. The aim of this observational study was to evaluate the effect of nocturnal respiratory-related indices based on nocturnal respiratory polygraphy on clinical outcomes (including mortality and non-fatal events) in patients with ischemic stroke.
Methods
A total of 328 consecutive patients (181 (55%) males, mean age 65.8 ± 11.2 years old) with confirmed ischemic stroke admitted to a stroke unit within 24 h after stroke onset were included in the analysis. All patients underwent standard diagnostic and treatment procedures, and sleep polygraphy was performed within the clinical routine in the first 72 h after admission. The long-term outcomes were assessed by cumulative endpoint (death of any cause, new non-fatal myocardial infarction, new non-fatal stroke/transient ischemic attack, emergency revascularization, emergency hospitalization due to the worsening of cardiovascular disease). A Cox-regression analysis was applied to evaluate the effects of nocturnal respiratory indices on survival.
Results
The mean follow-up period comprised 12 months (maximal—48 months). Patients with unfavourable outcomes demonstrated a higher obstructive apnea-hypopnea index, a higher hypoxemia burden assessed as a percent of the time with SpO2 < 90%, a higher average desaturation drop, and a higher respiratory rate at night. Survival time was significantly lower (30.6 (26.5; 34.7) versus 37.9 (34.2; 41.6) months (Log Rank 6.857, p = 0.009)) in patients with higher hypoxemia burden (SpO2 < 90% during ≥2.1% versus
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Almazov National Medical Research Centre, 197341 St. Petersburg, Russia.
- Department of Clinical Psychology, Herzen State Pedagogical University, 191186 St. Petersburg, Russia.
- Medical Faculty, Pavlov University, 197022 St. Petersburg, Russia.
- Biology Faculty, Saint Petersburg State University, 199034 St. Petersburg, Russia.
ORCID-Profile: Mikhail Bochkarev, Sofia Osipenko, Vladislav Zheleznyakov, Alexey Gordeev
Förderung
- Russian Science Foundation
Zitieren
APA
Korostovtseva, L., Bochkarev, M., Amelina, V., Nikishkina, U., Osipenko, S., Vasilieva, A., Zheleznyakov, V., Zabroda, E., Gordeev, A., Golovkova-Kucheryavaia, M., Yanishevskiy, S., Sviryaev, Y., & Konradi, A. (2023). Sleep-Disordered Breathing and Prognosis after Ischemic Stroke: It Is Not Apnea-Hypopnea Index That Matters. Diagnostics, 13(13), 2246. https://doi.org/10.3390/diagnostics13132246
Vancouver
Korostovtseva L, Bochkarev M, Amelina V, Nikishkina U, Osipenko S, Vasilieva A, et al. Sleep-Disordered Breathing and Prognosis after Ischemic Stroke: It Is Not Apnea-Hypopnea Index That Matters. Diagnostics. 2023;13(13):2246. doi:10.3390/diagnostics13132246
BibTeX
@article{Korostovtseva2023,
author = {Korostovtseva, Lyudmila and Bochkarev, Mikhail and Amelina, Valeria and Nikishkina, Uliana and Osipenko, Sofia and Vasilieva, Anastasia and Zheleznyakov, Vladislav and Zabroda, Ekaterina and Gordeev, Alexey and Golovkova-Kucheryavaia, Maria and Yanishevskiy, Stanislav and Sviryaev, Yurii and Konradi, Aleksandra},
title = {Sleep-Disordered Breathing and Prognosis after Ischemic Stroke: It Is Not Apnea-Hypopnea Index That Matters},
journal = {Diagnostics},
year = {2023},
volume = {13},
number = {13},
pages = {2246},
doi = {10.3390/diagnostics13132246}
}
EUVIMED